Company Monitoring Page for Mallinckrodt

latest headlines for company on cafepharma

5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
Motley Fool
Sun, 11/20/16 - 05:33 pm
Tags:
Medicare, H.P. Acthar Gel, Mallinckrodt, Remodulin, United Therapeutics, Tyvaso, Provenge, Valeant Pharmaceuticals, Gilead Sciences, Harvoni
Mallinckrodt sharpens specialty pharma focus
BioPharma Dive
Sat, 08/27/16 - 09:48 am
Tags:
Mallinckrodt, M&A, IBA Molecular, nuclear imaging
Mallinckrodt plans regen med acquisition
BioPharma Dive
Sat, 08/13/16 - 03:11 pm
Tags:
Mallinckrodt, M&A, Stratatech, devices, burns
FDA warns Mallinckrodt for not submitting pediatric study for its opioid
Stat
Thu, 07/7/16 - 04:04 pm
Tags:
FDA, Mallinckrodt, pediatric, opioids, clinical trials, Xartemis XR
What’s Driving Growth for Mallinckrodt’s Acthar?
Yahoo/Market Realist
Sat, 05/14/16 - 12:49 pm
Tags:
Mallinckrodt, Acthar
A Merger And Acquisition/Tax Inversion Idea That Will Probably Never Happen, But Should
Seeking Alpha
Thu, 04/14/16 - 09:29 am
Tags:
M&A, tax inversions, Pfizer, Allergan, Valeant Pharmaceuticals, Mallinckrodt
Mallinckrodt's Acthar Will Raise It Up, Not Bring It Down
Seeking Alpha
Sat, 12/12/15 - 01:54 pm
Tags:
Mallinckrodt, Acthar, Gilead Sciences, Valeant Pharmaceuticals
Mallinckrodt boosts buyback plan amid news of a 2,000% price hike on infant drug
Fierce Pharma
Thu, 11/19/15 - 04:47 pm
Tags:
Mallinckrodt, share repurchase, Synacthen Depot
How a price hike for a drug for infants with epilepsy drove an uproar
Stat
Tue, 11/17/15 - 05:48 pm
Tags:
drug pricing, epilepsy, Mallinckrodt, Synacthen Depot
5 Drugs That Are the Face of Prescription Drug Reform
Motley Fool
Sun, 11/15/15 - 11:31 am
Tags:
H.P. Acthar Gel, Mallinckrodt, Harvoni, Gilead Sciences, Orkambi, Vertex Pharmaceuticals, Isuprel, Nitropress, Valeant Pharmaceuticals
Drugmakers Are Distancing Themselves From Valeant
Bloomberg
Fri, 10/23/15 - 05:10 pm
Tags:
Valeant Pharmaceuticals, Endo International, Allergan, Horizon Pharma, Mallinckrodt
This Drugmaker Suffered the Consequences of Price Increases
Bloomberg
Mon, 10/12/15 - 09:53 am
Tags:
Mallinckrodt, drug pricing, Ofirmev
Mallinckrodt buys immunotherapy maker Therakos in $1.33 billion deal
Yahoo/Reuters
Mon, 08/10/15 - 03:50 pm
Tags:
Mallinckrodt, Therakos, M&A
Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt
Fierce Pharma
Tue, 06/30/15 - 11:14 am
Tags:
Boehringer Ingelheim, generics, Hikma, Mallinckrodt, Perrigo Company, M&A
Mallinckrodt’s Questcor Said Facing States’ Antitrust Probe
Bloomberg
Thu, 06/18/15 - 10:55 am
Tags:
Mallinckrodt, Questcor, antitrust
FDA balks on generic Concerta as Mallinckrodt, Actavis meds gobble up market
Fierce Pharma
Wed, 06/17/15 - 11:25 am
Tags:
FDA, generics, Concerta, Mallinckrodt, Actavis, JNJ, ADHD
The FDA's Authority Challenged By Mallinckrodt
Yahoo/Benzinga
Sat, 05/16/15 - 02:06 pm
Tags:
FDA, Mallinckrodt, JNJ, Concerta, ADHD, generics
Mallinckrodt: Why The Ikaria Acquisition Is Positive For Investors
Seeking Alpha
Sun, 03/8/15 - 10:13 am
Tags:
Mallinckrodt, Ikaria, M&A
Mallinckrodt ponies up $2.3B for Ikaria and its neonatal respiratory med
Fierce Pharma
Thu, 03/5/15 - 11:07 am
Tags:
Mallinckrodt, Ikaria, neonatal, M&A
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
Tags:
M&A, Actavis, Allergan, Forest Labs, GSK, Novartis, Bayer, Merck, Cubist Pharma, Roche, InterMune, Mylan Labs, Abbott Labs, Questcor, Mallinckrodt, Eli Lilly, Sun Pharma, Ranbaxy

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.